SOSAFE
24.5.2023 08:01:30 CEST | Business Wire | Press release
SoSafe, Europe’s leading vendor for security awareness and training, today announced it has appointed two world-class cybersecurity industry leaders to its board: Tech executive Zeynep Inanoglu Ozdemir, former CMO at Palo Alto Networks, and Bhagwat Swaroop, experienced executive in the cybersecurity space and current President of Digital Security Solutions at Entrust.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230523005033/en/
Europe’s leading security awareness and training vendor SoSafe adds Zeynep Inanoglu Ozdemir, former CMO at Palo Alto Networks, to their board. (Photo: Business Wire)
Niklas Hellemann, CEO of SoSafe: “At SoSafe, we are at the forefront of security awareness innovation. Bringing two world-class industry leaders like Zeynep and Bhagwat for our board will strengthen our market expertise even further, boosting international expansion and product excellence. Advances in generative AI will inevitably lead to an escalation of the cyber threat landscape, particularly from a human risk perspective. We are delighted to welcome two highly experienced cybersecurity experts to our board, helping us to navigate this paradigm shift. SoSafe’s whole management team is very much looking forward to working with them.”
Zeynep Inanoglu Ozdemir has held key marketing leadership roles at Palo Alto Networks during a four-year period of rapid growth and transformation. As CMO, she has been responsible for launching an award-winning brand campaign for the company as well as pioneering the XDR category in cybersecurity at large. Previously, Ozdemir has worked at Palantir Technologies and Google, and currently sits on the board at iKSV, Turkey’s predominant arts and culture foundation. She holds a PhD in speech processing from Cambridge University, Machine Intelligence Lab, and a bachelor's degree in electrical engineering from Harvard University. Her deep expertise in category creation, data-driven marketing and growth strategies will be of great value to our board at SoSafe.
“Human-level risk management and security awareness programs are key capabilities in an increasingly automated threat landscape”, says Ozdemir. “I am very excited work with SoSafe to further their mission to drive secure behavior at scale.”
Bhagwat Swaroop is the President of Digital Security Solutions at Entrust and brings more than 20 years of leadership experience driving growth in global high-tech companies to the board. He was most recently president and General Manager of One Identity, where he led the company’s turnaround to a cloud-based cybersecurity company. Prior to One Identity, Swaroop was a Corporate Officer and Executive Vice President at Proofpoint responsible for driving company’s rapid growth and helped make Proofpoint the market leader in email security. Previously he held leadership positions at Symantec, NetApp, McKinsey, and Intel. He is a seasoned strategic leader and brings a deep understanding of the enterprise security landscape, technology ecosystem and cloud driven business models. He is a sought expert and public speaker on cybersecurity, cloud computing and national policy topics. “Security awareness training has become a foundational capability to make the human layer more resilient to the constant phishing attempts.” states Swaroop. “I was impressed by SoSafe’s deep focus on fusing behavioral science with cybersecurity awareness solutions. I am looking forward to working with the SoSafe leadership team in the next phase of their growth journey”.
With these new additions to its board, European security awareness leader SoSafe underlines its commitment for international expansion and product innovation.
_______________
About SoSafe
SoSafe empowers organizations to build a security culture and mitigate risk with its GDPR-compliant awareness programs. The company was founded in Cologne, Germany, in 2018 by Dr Niklas Hellemann, Lukas Schaefer, and Felix Schuerholz. Today, it serves more than 3000 customers worldwide and is the market leader in security awareness and training in the DACH region. As one of the leading second-generation awareness platforms, they are powered by behavioral science and smart algorithms and focus on user engagement and the needs of the customer. In doing so, SoSafe delivers engaging, personalized learning experiences and smart attack simulations that turn employees into active assets against online threats. The SoSafe team consists of more than 370 employees at five locations: Cologne (headquarters), Amsterdam, Berlin, London, and Paris.
Website: www.sosafe-awareness.com/
LinkedIn: https://www.linkedin.com/company/sosafe-cyber-security/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230523005033/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom